Introduction: A historic achievement in the health sector
The Saudi Arabian healthcare system achieved a historic milestone in 2025, with a sharp 50% decrease in infectious disease mortality rates. This exceptional success is a result of continuous efforts and effective policies in prevention, immunization, and the strategic expansion of early detection and epidemiological surveillance programs across all regions of the Kingdom. This significant reduction reflects the remarkable progress of the healthcare sector and its ability to respond swiftly to protect the community and reduce infection rates to unprecedented levels.
General and historical context: Vision 2030 and the health transformation
Historically, infectious diseases have posed a significant challenge to healthcare systems worldwide. In the Kingdom, the Health Sector Transformation Program, a cornerstone of Saudi Vision 2030, laid a solid foundation for comprehensive healthcare. The Vision emphasized the principle of "prevention is better than cure," leading to substantial investments in healthcare infrastructure, the development of epidemiological surveillance systems, and the provision of the latest vaccines and treatments to both citizens and residents. This strategic transformation paved the way for achieving these record-breaking figures by 2025.
Documented data: Elimination of viral hepatitis
Official data has revealed a historic 97% decrease in hepatitis C deaths. This achievement is not a coincidence, but a direct result of enhanced treatment programs, the provision of modern, highly effective medications, and intensified proactive screening. Similarly, statistics show a 61% decline in hepatitis B prevalence compared to 2015. These steps underscore the effectiveness of preventive measures and align with the World Health Organization's goals to eliminate viral hepatitis as a public health threat by 2030.
Comprehensive coverage of fortifications: an impenetrable defensive wall
Regarding national immunizations, the overall vaccination coverage rate jumped to 97.4% this year, compared to 95% in 2016. This high rate forms a strong barrier that ensures the achievement of herd immunity, effectively limiting the spread of vaccine-preventable diseases and epidemics. Medical reports also noted a rise in antiretroviral therapy coverage for HIV/AIDS patients, reaching 93%, surpassing the 88% recorded in 2020. This reflects the health system's commitment to providing continuous care and comprehensive support to all segments of the population.
Success of treatment plans to combat tuberculosis
Regarding chronic respiratory diseases, the incidence of tuberculosis decreased by 31%, coinciding with a remarkable success rate of 92% in treatment plans, surpassing the figures of 2023. Health outcomes confirmed that precise medical interventions and diligent follow-up contributed to reducing deaths resulting from tuberculosis by 26%.
Importance and expected impact: locally, regionally, and internationally
This achievement is of paramount importance on several levels. Locally , it contributes to raising the quality of life and increasing life expectancy, while also reducing the economic burden of treatment and hospitalization. Regionally , the Kingdom stands out as a leading model to be emulated in the Middle East in combating infectious diseases and managing public health. Internationally , these figures enhance the Kingdom's standing in global health organizations and underscore its ability to provide a safe and healthy environment, which is particularly crucial given that the Kingdom hosts millions of pilgrims annually, making its health security an integral part of global health security. This culminates in a year of significant health gains that strengthen the prospects for complete disease control.
